Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Health
Joseph James

UNBELIEVABLE: Rezdiffra whistleblower lawsuit claims madrigal forced out its former clinical chief over liver injury data concerns - The Untold Story

A former senior executive at Madrigal Pharmaceuticals has sued the company in federal court, alleging he was forced out after warning top leaders about liver-injury data tied to Rezdiffra, the first FDA-approved drug for the liver disease MASH. Michael Charlton, a physician who led clinical development from October 2024 until January 2026, filed the retaliation lawsuit on Oct. 9 in the U.S. District Court for the Northern District of Illinois, STAT reported.

Madrigal vigorously denies the accusations and defends the drug's safety, according to STAT. None of the claims has been tested in court, and no regulatory action tied to them has been announced.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.